Covista Inc. (CVSA) Stock
NYSE · CVSA
119.27
Fundamentals
Market cap
$4.11B
Price / Earnings ratio
16.8x
Price / Sales ratio
2.2x
Price / Book ratio
2.9x
Return on assets
9.0%
Ex-Dividend date
30 Nov 2016
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Here's Why Covista (CVSA) is a Strong Growth Stock
NeutralCVSASeptember 23, 2026
Zacks Investment ResearchNeutral
Here's Why Covista (CVSA) is a Strong Growth Stock
CVSA

Zacks Investment Research
Covista (CVSA) is a Top-Ranked Value Stock: Should You Buy?
NeutralCVSASeptember 16, 2026
Zacks Investment ResearchNeutral
Covista (CVSA) is a Top-Ranked Value Stock: Should You Buy?
CVSA

Business Wire
Chamberlain University to Open Nashville Campus; Now Accepting Applications for January 2027 Cohort
NeutralCVSASeptember 9, 2026
Business WireNeutral
Chamberlain University to Open Nashville Campus; Now Accepting Applications for January 2027 Cohort
CVSA

Business Wire
Covista to Participate in September Investor Conferences
NeutralCVSASeptember 8, 2026
Business WireNeutral
Covista to Participate in September Investor Conferences
CVSA
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell10 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral1
Buy0
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
2026
2B2B774M0
Debt & Balance Sheet
Total assets
Total liabilities
2025
2026
4B2B1B0
Revenue to Profit
2026$2.0B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$251.6M
Net incomeEarnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Here's Why Covista (CVSA) is a Strong Growth Stock
NeutralCVSASeptember 23, 2026
Zacks Investment ResearchNeutral
Here's Why Covista (CVSA) is a Strong Growth Stock
CVSA

Zacks Investment Research
Covista (CVSA) is a Top-Ranked Value Stock: Should You Buy?
NeutralCVSASeptember 16, 2026
Zacks Investment ResearchNeutral
Covista (CVSA) is a Top-Ranked Value Stock: Should You Buy?
CVSA

Business Wire
Chamberlain University to Open Nashville Campus; Now Accepting Applications for January 2027 Cohort
NeutralCVSASeptember 9, 2026
Business WireNeutral
Chamberlain University to Open Nashville Campus; Now Accepting Applications for January 2027 Cohort
CVSA

Business Wire
Covista to Participate in September Investor Conferences
NeutralCVSASeptember 8, 2026
Business WireNeutral
Covista to Participate in September Investor Conferences
CVSA

Zacks Investment Research
Here's Why Covista (CVSA) is a Strong Momentum Stock
NeutralCVSASeptember 3, 2026
Zacks Investment ResearchNeutral
Here's Why Covista (CVSA) is a Strong Momentum Stock
CVSA

Zacks Investment Research
Here's Why Covista (CVSA) is a Strong Growth Stock
NeutralCVSASeptember 2, 2026
Zacks Investment ResearchNeutral
Here's Why Covista (CVSA) is a Strong Growth Stock
CVSA

Zacks Investment Research
Here's Why Covista (CVSA) is a Strong Value Stock
NeutralCVSAAugust 27, 2026
Zacks Investment ResearchNeutral
Here's Why Covista (CVSA) is a Strong Value Stock
CVSA

Zacks Investment Research
Here's Why Covista (CVSA) is a Strong Growth Stock
NeutralCVSAAugust 17, 2026
Zacks Investment ResearchNeutral
Here's Why Covista (CVSA) is a Strong Growth Stock
CVSA

The Motley Fool
Covista SVP Sells 4,526 Shares for $615,000
NeutralCVSAAugust 13, 2026
The Motley FoolNeutral
Covista SVP Sells 4,526 Shares for $615,000
CVSA

Zacks Investment Research
Why Covista (CVSA) is a Top Value Stock for the Long-Term
NeutralCVSAAugust 10, 2026
Zacks Investment ResearchNeutral
Why Covista (CVSA) is a Top Value Stock for the Long-Term
CVSA
About Covista Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.
SectorConsumer Defensive
IndustryEducation & Training Services
Employees4,736
CEOMr. Stephen W. Beard J.D.
IPO DateJun 21, 1991
HeadquartersChicago, IL
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen W. Beard J.D. | CEO & Chairman | 1971 |
| Mr. Robert J. Phelan CPA | Senior VP & CFO | 1966 |
| Mr. Douglas G. Beck J.D. | Senior VP of Institutional Support Services, General Counsel & Corporate Secretary | 1967 |
| Mr. Michael Betz | Chief Growth & Innovation Officer and President of Walden University | 1974 |
| Mr. Scott Day Liles | Chief Strategy & Performance Officer and President of Medical and Veterinary | 1966 |
| Mr. Manjunath Gangadharan | VP & Chief Accounting Officer | 1983 |
| Mr. Jeremy Cohen | Vice President of Investor Relations | — |
| Ms. Sara Hill | Senior VP & Chief Human Resources Officer | 1969 |
| Ms. Megan Noel | Senior VP & Chief Corporate Affairs Officer | 1985 |
| Ms. Amelia Manning | President of Chamberlain University | 1974 |
Fundamentals
Valuation
Market cap$4.11B
Price-to-sales ratio2.16
Price-to-book value2.92
Price-earnings ratio16.80
Return on Equity17.00%
Return on Sales19.00%
Return on Assets9.00%
PEG ratio0.91
Earnings Per Share
Earnings Per Share$7.18
Income Statement
Average volume342,346
EBITDA$438.67M
1 year high (52w)$142.13
1 year low (52w)$94.11
Dividend
Ex dividend date30 Nov 2016
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell10 Indicators
What the experts say
1 Wall Street Analyst Ratings
HOLD
0% Buy
100% Hold
0% Sell
Target price
$140.00
Est return
15.91%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.6 | +15.5 | -1.2 | +3.5 | +2.1 | -2.6 | +3.8 | -9.6 |



